Owners, management and financials
CVR: 37064408
Secondary names: Eurofins Pharma Holding Denmark A/S, Eurofins BioPharma Product Testing & Professional Scientific Services Denmark Holding A/S
Previous names: Eurofins Pharma Holding Denmark A/S, Eurofins BioPharma Product Testing & Professional Scientific Services Denmark Holding A/S
DKK -163,266
Gross profit
Net result: DKK 8,356,614
Eurofins Pharma Services LUX Holding SARL (100%)
CVR · view owners
Stefánia Pcolová
Board: Svend Aage Linde (chair) and 2 members
CVR · view management
Active
Founded 31 August 2015
CVR · view overview
0 employees
Annual report 2025 · average
Name registered: Eurofins BioPharma Product Testing Denmark Holding A/S
CVR · 20/10/2022
View the full event history
Eurofins BioPharma Product Testing Denmark Holding A/S is a Danish company of the type Aktieselskab based in Galten, founded in 2015. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Eurofins BioPharma Product Testing & Professional Scientific Services Denmark Holding A/S and Eurofins Pharma Holding Denmark A/S. The management consists of Stefánia Pcolová. The board consists of Svend Aage Linde (chair), Jan Rando and Marco Antonio Giuseppe Baeli. The company is owned by Eurofins Pharma Services LUX Holding SARL. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -163,266 and a net result of DKK 8,356,614 compared with DKK -1,877,244 the year before. Equity in the 2025 report amounted to DKK 24,787,263.
Selskabets formål er at udøve investeringsvirksomhed, herunder ved besiddelse af kapitalandele i et eller flere datterselskaber.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -163K | 8.4M | 71M | 24.8M | 0 | |
| 202401/01/2024 – 31/12/2024 | -104K | -1.9M | 62.8M | 16.4M | - | |
| 202301/01/2023 – 31/12/2023 | -93K | 3.6M | 66.5M | 20.1M | - | |
| 202201/01/2022 – 31/12/2022 | -88K | 7.9M | 65.1M | 18.8M | - | |
| 202101/01/2021 – 31/12/2021 | -82K | 4.3M | 61.2M | 15.2M | - | |
| 202001/01/2020 – 31/12/2020 | -80K | 5.3M | 61.9M | 15.9M | - | |
| 201901/01/2019 – 31/12/2019 | -81K | 3.3M | 59.6M | 13.6M | - | |
| 201801/01/2018 – 31/12/2018 | -83K | 8.1M | 60.3M | 15M | - | |
| 201701/01/2017 – 31/12/2017 | -110K | 910K | 59.9M | 14.4M | - | |
| 201601/01/2016 – 31/12/2016 | -175K | 584K | 62.6M | 14M | - |
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Eurofins BioPharma Product Testing Denmark Holding A/S is 37064408.
Eurofins BioPharma Product Testing Denmark Holding A/S is owned by Eurofins Pharma Services LUX Holding SARL.
The management of Eurofins BioPharma Product Testing Denmark Holding A/S consists of Stefánia Pcolová.
The board of Eurofins BioPharma Product Testing Denmark Holding A/S consists of Svend Aage Linde, Jan Rando and Marco Antonio Giuseppe Baeli, with Svend Aage Linde as chair.
In 2025, Eurofins BioPharma Product Testing Denmark Holding A/S reported a gross profit of DKK -163,266.
Eurofins BioPharma Product Testing Denmark Holding A/S had an average of 0 employees in the 2025 financial year according to the annual report.
Claim this page to add your logo and social links. Free to get started.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2025. Gross profit came to DKK -163,266, and the net result was DKK 8,356,614.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2024. Gross profit came to DKK -103,878, and the net result was DKK -1,877,244.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2023. Gross profit came to DKK -92,640, and the net result was DKK 3,606,153.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2022. Gross profit came to DKK -87,649, and the net result was DKK 7,900,329.
On October 20, 2022, the company changed its name from Eurofins BioPharma Product Testing & Professional Scientific Services Denmark Holding A/S to Eurofins BioPharma Product Testing Denmark Holding A/S.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2021. Gross profit came to DKK -82,400, and the net result was DKK 4,303,830.
On February 18, 2022, the company changed its name from Eurofins Pharma Holding Denmark A/S to Eurofins BioPharma Product Testing & Professional Scientific Services Denmark Holding A/S.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2020. Gross profit came to DKK -79,990, and the net result was DKK 5,272,479.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2019. Gross profit came to DKK -80,588, and the net result was DKK 3,326,352.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2018. Gross profit came to DKK -83,448, and the net result was DKK 8,065,821.
As of May 10, 2019, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of May 10, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of April 9, 2019, Marco Antonio Giuseppe Baeli has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of April 9, 2019, Berthold Jakob Georg Hackl has left the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of October 15, 2018, Jan Rando has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of October 15, 2018, Jacob Klinge Jacobsen has left the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2017. Gross profit came to DKK -109,688, and the net result was DKK 910,248.
As of February 9, 2018, Jacob Klinge Jacobsen has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of February 9, 2018, Thomas Gjelsnes has left the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of January 1, 2018, Stefánia Pcolová is registered as adm. dir. of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of January 1, 2018, Thomas Gjelsnes has stepped down as adm. dir. of Eurofins BioPharma Product Testing Denmark Holding A/S.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its annual report for 2016. Gross profit came to DKK -174,784, and the net result was DKK 583,998.
Eurofins BioPharma Product Testing Denmark Holding A/S has published its interim report for the period August 31, 2015 to December 31, 2015.
As of August 31, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of August 31, 2015, Svend Aage Linde has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of August 31, 2015, Thomas Gjelsnes has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of August 31, 2015, Berthold Jakob Georg Hackl has joined the board of directors of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of August 31, 2015, Thomas Gjelsnes is registered as adm. dir. of Eurofins BioPharma Product Testing Denmark Holding A/S.
As of August 31, 2015, is registered as an owner of Eurofins BioPharma Product Testing Denmark Holding A/S with an ownership share of 100%.
Eurofins BioPharma Product Testing Denmark Holding A/S was founded on August 31, 2015.
Companies in the same industry and area
CVR 37757322
CVR 35478744
CVR 41373873
CVR 39576147
CVR 28114931
